This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk01: Good day and thank you for standing by. Welcome to the Go Health second quarter 2023 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising you that your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, John Shave, Vice President, Investor Relations. Please go ahead.
spk06: Thank you, and good morning, everyone.
spk07: Thanks for joining GO Health's second quarter 2023 earnings call. Joining me today are Vijay Kote, Chief Executive Officer, and Jason Scholz, Chief Financial Officer. Today's conference call contains forward-looking statements based on our current expectations. Numerous risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events, or otherwise. Earlier today, we issued a press release containing our results for the second quarter of 2023. We have posted the release on the GoHealth website under the Investor Relations tab. In the press release, we've listed a number of risk factors which you should consider in conjunction with our forward-looking statements. We encourage you to consider the other risk factors described in our Form 10-K and Form 10-Q reports filed with the Securities and Exchange Commission for additional information. During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure, and the reconciliations are set forth in the press release. Please refer to the investor relations section of our website for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed this earnings call. I'll now turn the call over to GoHealth CEO, Vijay Kote.
spk05: Thank you, John. Good morning, and thank you all for joining us today. I'm pleased to report another strong quarter. Together with our external partners, we helped over 162,000 Medicare consumers assess their coverage, review potential Medicare options, and enroll in a plan. Our marketplace model is distinct from traditional brokers in several ways. At GoHealth, we remain unbiased and put the consumer at the center of all we do. We achieved $140 million in revenue, nearly $1 million in adjusted EBITDA, and almost $11 million in positive cash flows. We continue to see improved profitability as we accomplished a significant milestone by reaching positive adjusted EBITDA in Q2, compared to a loss of just under $32 million in the second quarter of 2022, which is particularly noteworthy given the historical dynamics of losses in the quarter due to carrying costs versus volume. This accomplishment is a testament to the intentional resizing decisions we made last year, which had a positive impact on our exit runways. Additionally, our strategic deployment of automation and technology played a pivotal role in driving operational efficiency while turning the corner to prudent growth going forward on a year-over-year basis. Our growth and exceptional results have exceeded expectations, providing us with the confidence to elevate our financial guidance for the remainder of the year. With this impressive performance, we now expect 2023 total net revenue of between $800 million and $850 million, an increase from the previous lower bound of $750 million. Furthermore, our projected adjusted EBITDA range is set to reach between $120 million and $140 million, surpassing the previously lower bound of $100 million. Please recall that our guidance excludes non-encompassed BTO services. I want to highlight that with our strategic exit of non-encompassed BTO services, we believe we have transitioned to a phase of profitable growth accompanied by improving cash flow generation. You can see this in our second quarter results as compared to last year, and we expect this to continue for the rest of 2023, as also evident in our revised guidance. We are driving efficiencies in the best way possible, by doing more with the same. And this applies to our seasoned agents, streamlined onboarding process, standardized encompass model, and proprietary technology, all of which we expect to continue to improve and enhance. As we said in Q4 2022, Medicare plan shopping will increase It has increased, as both peers and partners have recently confirmed. We believe beneficiaries now switch plans as many as three to five times over the course of their eligibility as their needs change, though they should shop at least once a year. We anticipated last year that consumer shopping would continue and may impact churn. The increase in consumer shopping was a driver of the change in estimate we did at the end of 2022, and we took that into account for our 2023 guidance. If consumers are going to shop, we want them to shop with us, regardless of whether we originally enrolled them in their plan. More consumers will shop with us if we build a trusted relationship by delivering an unbiased, high-quality consumer shopping experience. This approach leverages an agnostic consumer marketplace with multiple plan options and develops credibility with consumers. We want to be the destination that provides consumers with a needs-based checkup every year, where the results might mean the consumer stays in their current plan if it is the best plan for their needs. If it is not the best plan, we make it easy to enroll in the better one. We remain committed to enhancing the personalization of the consumer experience, which has been a driving force behind our Encompass transformation. As we have stated in the past, we expect planned shopping to continue to increase, and our long game is to invest in relationships and align incentives. We are providing a trustworthy shopping experience that allows consumers to select a Medicare plan that meets their unique needs. With the Go Health shopping experience, Built on the Encompass operating model, we offer a personalized, unbiased, and no-pressure shopping experience where consumers can feel comfortable and confident throughout the entire process, focused on shopping and not selling. Most of the time, shopping does not result in an enrollment, especially if we find that a consumer is already on the best plan. But we believe it should always result in a discussion on the best option for them. We have recently implemented the PlanFit Checkout, where we are compensating our agents or their time spent with consumers, even if they assess that the current plan remains the strongest fit for them in their service area and no switching is needed at that time. We view the PlanFit Checkup as an investment in a long-term relationship with the consumer and believe the shopping process enhances trust, even if the interaction with the consumer doesn't result in a new enrollment today. We developed the PlanFit Checkup throughout Q2 and recently launched it in Q3. Preliminary results show improved agent and consumer sentiment with limited operational impacts, indicating more robust consumer and agent experience. Our agents are excited about the PlanFit checkup, and we believe it could help us become the broker of choice for agents. This investment is contemplated in our guidance and plan. As we discussed last quarter, we continue to enhance our technology to drive overall efficiency in our model and improve the consumer experience. Our PlanFit tool is built on millions of consumer interactions, and leverages that data to create a customized, guided, multi-step shopping experience. The tool continues to evolve as we write more policies, gather more data, and add model features. Our testing continues to build momentum, with the last AEP showing plans ranked number one by PlanFit were both the most selected for consumers and had 10% higher 90-day retention. Our unified agent experience has streamlined and enhanced the process for agents to assist consumers as well as improved compliance and efficiency. Onboarding for new agents has been reduced by 33%. In Q2, we successfully launched a new guided experience to all agents, delivering approximately 5% improvement in quality scores and path to competency for new agents. We are excited about the possibilities that lie ahead and look forward to redefining excellence in consumer experience. Finally, I'm delighted to share the significant strides we're making with the operationalization and implementation of Customer 360, a transformative data initiative that drives improvement now and serves as a foundation for GoHealth's future. In the near term, Customer 360 drives better call routing, better organization of consumer data, and improved ability to recall consumer data. Based on our proprietary matching algorithms, we can clearly measure that just over 20% of our inbound calls are coming from previous shoppers who may or may not have enrolled through us but can now have a more streamlined, consistent experience only verifying information as opposed to starting from scratch. In the future, we expect Customer 360 will revolutionize the way we interact with consumers and consider each consumer's historical relationship with Go Health. This will drive meaningful, improved efficiency for our agents and prepare us to succeed in the future, where consumers are empowered to enroll in and manage their Medicare Advantage on their own terms, whether telephonically, digitally, or some combination of the two. Our belief in the Encompass model's value for health plans is backed by our ability to redefine and reset the foundation of our business through our new contracts. We have entered multi-year Encompass contracts with nearly all our major health plan partners, making it clear that Encompass and the verified enrollment and plan onboarding processes that we have developed will position us to deliver a world-class consumer experience. Alongside these multi-year contracts with our health plan partners, we believe our incentives are set up in a way that will allow us to best support consumers to shop for the best plant and incent health plan partners to continue to invest in competitive products to win and retain consumers. As we've introduced and rolled out our guided shopping process at scale across our Tier 2 agents, we have been able to expand the number of health plans we offer to our consumers, ensuring that the most competitive product in the region is available to them. We are focused on active rates of the members we place in health plans, ensuring that we will deliver higher effectuation and 90-day active rates for our health plan partners. We also realize that consumer needs will not stay static over time, and we owe it to our consumers to help them assess their options as new plans become available in their area and decide whether to try something new or stay where they are. Our redefined Encompass solution has driven higher quality enrollment, resulting in fewer CTMs, higher effectuation rates, and greater member retention. As always, AEP preparation is a key focus for us. We are on track with our staffing and training plan along with our operational and product-focused work slated to be released prior to AEP, resulting in a more efficient agent experience. We continue to collaborate with our health plan partners and remain confident that we will successfully be able to navigate the CMS final rule changes, inclusive of the 48-hour rule, and are supportive of CMS's position to strengthen the consumer experience. The efficiency we are driving with our Encompass model is flowing through our financials with lower cash burns and lower costs. delivering economies of scale and revenue reliability while reinforcing a consistent and high-quality consumer experience. With that, I'd like to thank our team and partners for the loyalty and dedication during this transformative time. And I'll now turn it over to Jason to detail the financials and our updated guide.
spk10: Thanks, Vijay. I'm pleased to present our Q2 2023 financial results. Our Q2 performance has exceeded expectations, with margin expansion and improved operational efficiency leading to a strong quarter. Second quarter revenue, after adjusting for the exit of our non-encompassed BTO services, was $140.3 million, demonstrating growth compared to the $138.7 million generated in the second quarter of last year. While our year-over-year growth is modest, we are pleased to be turning the corner for long-term sustained top and bottom-line financial growth. Our strong Q2 revenue performance was driven by over 162,000 submissions, representing an increase of 5% year-over-year. Our second quarter adjusted EBITDA of $800,000 marks a $33 million improvement compared to the same period last year. The year-over-year increase is largely driven by the continued benefits from the encompass operating model, which has created significant efficiency gains. These improvements are a testament to our continued commitment for sustained growth and profitability. In Q2, we recorded $11 million for legal exposure related to our securities litigation. This accrual is not indicative of any procedural developments in the litigation, and we remain confident in our defenses. In the second quarter of 2023, we achieved $11 million of positive cash flow from operations, a significant turnaround from the negative cash flow of $48 million in the prior year period. As illustrated in our quarterly results presentation posted on our website, our trailing 12-month cash flow from operations as of Q2 2023 is $86 million. This accomplishment represents a $346 million improvement compared to the same trailing 12-month period last year. While $107 million of this improvement can be attributed to the non-agency revenue, $254 million of the change is driven by our more efficient Encompass operating model. In Q2, we made a payment of $14 million on our term loan, which reduces our outstanding debt balance to $496 million compared to $667 million of total debt in Q2 of 2022. This results in a reduction of $171 million of debt, or 25% over the last 12 months. Consistent with the performance highlighted in our last quarterly earnings call, we continue to see strong momentum in our unit economics. Our unwavering commitment to driving high-quality enrollment and leveraging our proprietary tools and technology has yielded remarkable operational efficiency. As outlined in our quarterly results presentation, our Q2 2023 adjusted gross margin per submission was $127, marking an impressive 443% increase in profitability as compared to the prior year period. Compared to prior year, we increased our agency commission constraint, which led to a year-over-year decline in sales per submission. However, this was more than offset by the significant efficiencies gained evident in the noteworthy 21% improvement in cost per submission. Our continued growth and strong, year-to-date performance enable us to raise the floor and narrow our guidance for the fiscal year, reflecting the confidence we have in our trajectory. As Vijay mentioned, we now expect total revenue between $800 million and $850 million, an increase from the previous lower bound of $750 million. Furthermore, our updated projected adjusted EBITDA range is $120 million and $140 million, surpassing the previous lower bound of $100 million. Please recall that our guidance includes non-encompassed BPO services. We are maintaining our current range for cash flow from operations of $75 million to $115 million. As I mentioned in our prior call, our typical seasonality for revenue and adjusted EBITDA peaks during Q4, driven by the annual enrollment period, followed by Q1, featuring the open enrollment period, while Q2 and Q3 typically experience more modest revenues and negative adjusted EBITDA. due to the lower volumes in the special enrollment period. While we do not guide on a quarterly basis, we do anticipate Q3 to experience sequential declines in revenue and adjusted data compared to Q2, but expected to outperform Q3 of last year. We believe our updated guidance illustrates our commitment to drive profitability growth and execute through the more efficient and toughest operating model. The impressive strides we've made are a testament to the dedication of our exceptional team and the effectiveness of our strategic initiatives. We are generating cash and have clear line of sight to achieving our target leverage ratio in Q4 of this year. This is a significant milestone in our journey towards long-term financial strength and stability, setting the stage for continued success and unlocking new opportunities for growth.
spk05: I'll now turn it over to Vijay for closing remarks. Before I move to the question and answer session, I want to first make a brief comment on a recent conference. In May, our board of directors confirmed that it had received an unsolicited acquisition proposal. The details can be found in our SEC files. We also announced that our board had established a special committee of independent directors to carefully consider the proposal receipt. As included in our earnings release, the special committee has concluded that the offer undervalues the company and is not in the best interest of GoHealth or its stockholders. We do not have any further updates at this time. We remain appreciative of the continued support and trust from our stockholders. We are focused on delivering value and driving the success of our business while maintaining high standards of corporate governance. With that, we would like to open the call to questions. Operator?
spk01: Thank you. As a reminder, if you have a question at this time, please press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. One moment for our first question. Our first question comes from the line of Ben Hendrix with RBC Capital Markets. Your line is open. Please go ahead.
spk03: Great. Thank you very much. Congratulations on the quarter. Can you remind us of the mix of encompassed revenue assumed in four-year guidance and then how you're thinking about that evolving over time?
spk10: Thank you. Yeah. Ben, thanks for the question. So we are not going to go ahead and provide the mixed assumption for Encompass for the full year guidance, but we do believe that it will have a meaningful improvement into our cash flow from operations for the rest of the year. Additionally, I think what's important, as we talked about in the last quarter, when we have our Encompass model, our operating model, materially all of our business is going through that operations. And so I think that's the more important point because that is going to go ahead and continue to drive the more efficient outcomes that we're talking about on the cost per submission. And so that's the primary thing I would guide you towards.
spk05: Yeah, and I'll add to that, Ben, that just as a disclaimer, right, we said early on this year with all the hard work the team's done that we wanted to standardize on the Encompass workflow. And that was for our internal captive channel. As you know, you have the external downline agencies who work with us and collaborate with us, but they're not on that same platform. So you would see the lion's share, if not all, of the volume running through the Encompass platform and the internal captive agents. And then externally, though we're starting to test that model, it's going to be a small portion of that. And so the majority of our external production will be running through the agency line. with the lion's share of the internal volume going through the non-agency line. So hopefully that's helpful to you, but I think it's confident to say that nearly all of the internal volume is going to be running through the encompass workflow.
spk03: Thanks for that, Collar. And then separately, I was wondering if you could give us an update on how agent retention is trending. It seems like this plan fit checkup would be a Good way to support agent retention. Just any comments there?
spk05: Yeah, no. Thanks, Ben. On the question, I would say that our team has been super excited about what we've been doing with the tools we're providing for them to make their jobs easier, make it more efficient, a more standardized workflow that comes through Encompass. We have really committed and said out loud, as we said on these calls, that we were going to commit to doing the right thing and even paying our agents for not enrolling a beneficiary, but giving them a high-quality selling or shopping experience. And that was really important to us. So we augmented our compensation plans to do just that. If they deliver a high-quality shopping experience where they assess the individual's needs, match them with plans, present those to them, And even if they decide that they're already in the right plan and they tell them that, they will be compensated for that time that they spent and the high-quality work they did. That on top of the efficiencies delivered by our unified agent experience and even bringing in customer 360s, those bring efficiencies into the process that allow them to speak to more beneficiaries and more of our consumers. And so that gives them an opportunity to make more ultimately in that process. So with all those tools and our commitment to doing the right thing, which our agents want to do the right thing, and when we say we're now going to compensate them, even though many of them were already doing it, but now that we're compensating them for doing that, they realize they were aligned in our intentions to support consumers. The effect of that has been that our attrition is lower than we expected, and we are able to recruit at a higher pace, and we're recruiting when we need to add new agents with a With agents who are actually already licensed, they're actually more experienced in the space. And so in total, it's been a very, very exciting transition that the team's been able to work towards to achieve higher satisfaction amongst that group by delivering them tools and a very unique compensation model that's unparalleled in the industry.
spk11: Thank you.
spk01: Thank you, and I'm showing no further questions at this time, and I'd like to hand the conference back over to Vijay Kote for any further remarks.
spk05: Thanks again for joining us today. We are really excited about our progress. It is safe to say that we have been on a transformation. It has been an interesting transition over that timeframe, over the last year plus. We deployed our Encompass strategy, and it worked. We have shifted and can really stay focused to the fact that we've built a strong foundation from which now to grow as we were able to grow this quarter with half of the agents that we used to have but still have year-over-year growth in this channel, built off of the hard work of our team. And so we hope you leave knowing we remain focused on delivering long-term value for our shareholders while providing high-quality experiences to our consumers and health plans. Thank you for your continued support. And we look forward to updating you on our progress during our next quarterly results call and webcast. Thank you.
spk01: This concludes today's conference call. Thank you for participating. You may now disconnect.
spk00: Thank you. you Thank you. Thank you.
spk01: Good day and thank you for standing by. Welcome to the Go Health second quarter 2023 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 11 on your telephone. You will then hear an automated message advising you that your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, John Shave, Vice President, Investor Relations. Please go ahead.
spk06: Thank you, and good morning, everyone.
spk07: Thanks for joining GO Health's second quarter 2023 earnings call. Joining me today are Vijay Kote, Chief Executive Officer, and Jason Scholz, Chief Financial Officer. Today's conference call contains forward-looking statements based on our current expectations. Numerous risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events, or otherwise. Earlier today, we issued a press release containing our results for the second quarter of 2023. We have posted the release on the GoHealth website under the Investor Relations tab. In the press release, we've listed a number of risk factors which you should consider in conjunction with our forward-looking statements. We encourage you to consider the other risk factors described in our Form 10-K and Form 10-Q reports filed with the Securities and Exchange Commission for additional information. During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure, and the reconciliations are set forth in the press release. Please refer to the investor relations section of our website for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed this earnings call. I'll now turn the call over to GoHealth CEO Vijay Kote.
spk05: Thank you, John. Good morning, and thank you all for joining us today. I'm pleased to report another strong quarter. Together with our external partners, we helped over 162,000 Medicare consumers assess their coverage, review potential Medicare options, and enroll in a plan. Our marketplace model is distinct from traditional brokers in several ways. At GoHealth, we remain unbiased and put the consumer at the center of all we do. We achieved $140 million in revenue, nearly $1 million in adjusted EBITDA, and almost $11 million in positive cash flows. We continue to see improved profitability as we accomplished a significant milestone by reaching positive adjusted EBITDA in Q2, compared to a loss of just under $32 million in the second quarter of 2022, which is particularly noteworthy given the historical dynamics of losses in the quarter due to carrying costs versus volume. This accomplishment is a testament to the intentional resizing decisions we made last year, which had a positive impact on our exit runways. Additionally, our strategic deployment of automation and technology played a pivotal role in driving operational efficiency while turning the corner to prudent growth going forward on a year-over-year basis. Our growth and exceptional results have exceeded expectations, providing us with the confidence to elevate our financial guidance for the remainder of the year. With this impressive performance, we now expect 2023 total net revenue of between $800 million and $850 million, an increase from the previous lower bound of $750 million. Furthermore, our projected adjusted EBITDA range is set to reach between $120 million and $140 million, surpassing the previously lower bound of $100 million. Please recall that our guidance excludes non-encompassed BTO services. I want to highlight that with our strategic exit of non-encompassed BTO services, we believe we have transitioned to a phase of profitable growth accompanied by improving cash flow generation. You can see this in our second quarter results as compared to last year, and we expect this to continue for the rest of 2023 as also evident in our revised guidance. We are driving efficiencies in the best way possible by doing more with the same, and this applies to our seasoned agents, streamlined onboarding process, standardized encompass model, and proprietary technology, all of which we expect to continue to improve and enhance. As we said in Q4 2022, Medicare plan shopping will increase It has increased, as both peers and partners have recently confirmed. We believe beneficiaries now switch plans as many as three to five times over the course of their eligibility as their needs change, though they should shop at least once a year. We anticipated last year that consumer shopping would continue and may impact churn. The increase in consumer shopping was a driver of the change in estimate we did at the end of 2022, and we took that into account for our 2023 guidance. If consumers are going to shop, we want them to shop with us, regardless of whether we originally enrolled them in their plan. More consumers will shop with us if we build a trusted relationship by delivering an unbiased, high-quality consumer shopping experience. This approach leverages an agnostic consumer marketplace with multiple plan options and develops credibility with consumers. We want to be the destination that provides consumers with a needs-based checkup every year, where the results might mean the consumer stays in their current plan if it is best planned for their needs. If it is not the best plan, we make it easy to enroll in the better one. We remain committed to enhancing the personalization of the consumer experience, which has been a driving force behind our Encompass transformation. As we have stated in the past, we expect planned shopping to continue to increase, and our long game is to invest in relationships and align incentives. We are providing a trustworthy shopping experience that allows consumers to select a Medicare plan that meets their unique needs. With the Go Health shopping experience, Built on the Encompass operating model, we offer a personalized, unbiased, and no-pressure shopping experience where consumers can feel comfortable and confident throughout the entire process, focused on shopping and not selling. Most of the time, shopping does not result in an enrollment, especially if we find the consumer is already on the best plan. But we believe it should always result in a discussion on the best option for them. We have recently implemented the PlanFit Checkout, where we are compensating our agents or their time spent with consumers, even if they assess that the current plan remains the strongest fit for them in their service area and no switching is needed at that time. We view the PlanFit Checkup as an investment in a long-term relationship with the consumer and believe the shopping process enhances trust, even if the interaction with the consumer doesn't result in a new enrollment today. We developed the PlanFit Checkup throughout Q2 and recently launched it in Q3. Preliminary results show improved agent and consumer sentiment with limited operational impacts, indicating more robust consumer and agent experience. Our agents are excited about the PlanFit checkup, and we believe it could help us become the broker of choice for agents. This investment is contemplated in our guidance and plan. As we discussed last quarter, we continue to enhance our technology to drive overall efficiency in our model and improve the consumer experience. Our PlanFit tool is built on millions of consumer interactions, and leverages that data to create a customized, guided, multi-step shopping experience. The tool continues to evolve as we write more policies, gather more data, and add model features. Our testing continues to build momentum, with the last AEP showing plans ranked number one by PlanFit were both the most selected for consumers and had 10% higher 90-day retention. Our unified agent experience has streamlined and enhanced the process for agents to assist consumers onboarding, as well as improved compliance and efficiency. Onboarding for new agents has been reduced by 33%. In Q2, we successfully launched a new guided experience to all agents, delivering approximately 5% improvement in quality scores and path to competency for new agents. We are excited about the possibilities that lie ahead and look forward to redefining excellence in consumer experience. Finally, I'm delighted to share the significant strides we're making with the operationalization and implementation of Customer 360. a transformative data initiative that drives improvement now and serves as a foundation for GoHealth's future. In the near term, Customer 360 drives better call routing, better organization of consumer data, and improved ability to recall consumer data. Based on our proprietary matching algorithms, we can clearly measure that just over 20% of our inbound calls are coming from previous shoppers who may or may not have enrolled through us but can now have a more streamlined, consistent experience only verifying information as opposed to starting from scratch. In the future, we expect Customer 360 will revolutionize the way we interact with consumers and consider each consumer's historical relationship with GoHelp. This will drive meaningful, improved efficiency for our agents and prepare us to succeed in the future, where consumers are empowered to enroll in and manage their Medicare Advantage on their own terms, whether telephonically, digitally, or some combination of the two. Our belief in the Encompass model's value for health plans is backed by our ability to redefine and reset the foundation of our business through our new contracts. We have entered multi-year Encompass contracts with nearly all our major health plan partners, making it clear that Encompass and the verified enrollment and plan onboarding processes that we have developed will position us to deliver a world-class consumer experience. Alongside these multi-year contracts with our health plan partners, we believe our incentives are set up in a way that will allow us to best support consumers and incent health plan partners to continue to invest in competitive products to win and retain consumers. As we've introduced and rolled out our guided shopping process at scale across our Tier 2 agents, we have been able to expand the number of health plans we offer to our consumers, ensuring that the most competitive product in the region is available to them. We are focused on active rates of the members we place in health plans, ensuring that we will deliver higher effectuation and 90-day active rates for our health plan partners. We also realize that consumer needs will not stay static over time, and we owe it to our consumers to help them assess their options as new plans become available in their area and decide whether to try something new or stay where they are. Our redefined Encompass solution has driven higher quality enrollment, resulting in fewer CTMs, higher effectuation rates, and greater member retention. As always, AEP preparation is a key focus for us. We are on track with our staffing and training plan along with our operational and product-focused work slated to be released prior to AEP, resulting in a more efficient agent experience. We continue to collaborate with our health plan partners and remain confident that we will successfully be able to navigate the CMS final rule changes, inclusive of the 48-hour rule, and are supportive of CMS's position to strengthen the consumer experience. Efficiency we are driving with our Encompass model is flowing through our financials with lower cash burns and lower costs. delivering economies of scale and revenue reliability while reinforcing a consistent and high-quality consumer experience. With that, I'd like to thank our team and partners for the loyalty and dedication during this transformative time. And I'll now turn it over to Jason to detail the financials and our updated guide.
spk10: Thanks, Vijay. I'm pleased to present our Q2 2023 financial results. Our Q2 performance has exceeded expectations, with margin expansion and improved operational efficiency leading to a strong quarter. Second quarter revenue, after adjusting for the exit of our non-encompassed BPO services, was $140.3 million, demonstrating growth compared to the $138.7 million generated in the second quarter of last year. While our year-over-year growth is modest, we are pleased to be turning the corner for long-term sustained top and bottom-line financial growth. Our strong Q2 revenue performance was driven by over 162,000 submissions, representing an increase of 5% year-over-year. Our second quarter adjusted EBITDA of $800,000 marks a $33 million improvement compared to the same period last year. The year-over-year increase is largely driven by the continued benefits from the encompass operating model, which has created significant efficiency gains. These improvements are a testament to our continued commitment for sustained growth and profitability. In Q2, we recorded $11 million for legal exposure related to our securities litigation. This accrual is not indicative of any procedural developments in the litigation, and we remain confident in our defenses. In the second quarter of 2023, we achieved $11 million of positive cash flow from operations, a significant turnaround from the negative cash flow of $48 million in the prior year period. As illustrated in our quarterly results presentation posted on our website, our trailing 12-month cash flow from operations as of Q2 2023 is $86 million. This accomplishment represents a $346 million improvement compared to the same trailing 12-month period last year. While $107 million of this improvement can be attributed to the non-agency revenue, $254 million of the change is driven by our more efficient encompass operating model. In Q2, we made a payment of $14 million on our term loan, which reduces our outstanding debt balance to $496 million compared to $667 million of total debt in Q2 of 2022. This results in a reduction of $171 million of debt, or 25% over the last 12 months. Consistent with the performance highlighted in our last quarterly earnings call, we continue to see strong momentum in our unit economics. Our unwavering commitment to driving high-quality enrollment and leveraging our proprietary tools and technology has yielded remarkable operational efficiency. As outlined in our quarterly results presentation, our Q2 2023 adjusted gross margin per submission was $127, marking an impressive 443% increase in profitability as compared to the prior year period. Compared to prior year, we increased our agency commission constraint, which led to a year-over-year decline in sales per submission. However, this was more than offset by the significant efficiencies gained evident in the noteworthy 21% improvement in cost per submission. Our continued growth and strong, year-to-date performance enable us to raise the floor and narrow our guidance for the fiscal year, reflecting the confidence we have in our trajectory. As Vijay mentioned, we now expect total revenue between $800 million and $850 million, an increase from the previous lower bound of $750 million. Furthermore, our updated projected adjusted EBITDA range is $120 million and $140 million, surpassing the previous lower bound of $100 million. Please recall that our guidance includes non-encompassed BPO services. We are maintaining our current range for cash flow from operations of $75 million to $115 million. As I mentioned in our prior call, our typical seasonality for revenue and adjusted EBITDA peaks during Q4, driven by the annual enrollment period, followed by Q1, featuring the open enrollment period, while Q2 and Q3 typically experience more modest revenues and negative adjusted EBITDA. due to the lower volumes in the special enrollment period. While we do not guide on a quarterly basis, we do anticipate Q3 to experience sequential declines in revenue and adjusted data compared to Q2, but expected to outperform Q3 of last year. We believe our updated guidance illustrates our commitment to drive profitability growth and execute through the more efficient and toughest operating model. The impressive strides we've made are a testament to the dedication of our exceptional team and the effectiveness of our strategic initiatives. We are generating cash and have clear line of sight to achieving our target leverage ratio in Q4 of this year. This is a significant milestone in our journey towards long-term financial strength and stability, setting the stage for continued success and unlocking new opportunities for growth. I'll now turn it over to Vijay for closing remarks.
spk05: Before I move to the question and answer session, I want to first make a brief comment on a recent company. Phones and everything. In May, our board of directors confirmed that it had received an unsolicited acquisition proposal. The details can be found in our SEC files. We also announced that our board had established a special committee of independent directors to carefully consider the proposal receipt. As included in our earnings release, the special committee has concluded that the offer undervalues the company and is not in the best interest of GoHealth or its stockholders. We do not have any further updates at this time. We remain appreciative of the continued support and trust from our stockholders. We are focused on delivering value and driving the success of our business while maintaining high standards of corporate governance. With that, we would like to open the call to questions. Operator?
spk01: Thank you. As a reminder, if you have a question at this time, please press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. One moment for our first question. Our first question comes from the line of Ben Hendrix with RBC Capital Markets. Your line is open. Please go ahead.
spk03: Great. Thank you very much. Congratulations on the quarter. Can you remind us of the mix of encompassed revenue assumed in four-year guidance and then how you're thinking about that evolving over time?
spk10: Thank you. Yeah. Ben, thanks for the question. So we are not going to go ahead and provide the mixed assumption for Encompass for the full year guidance, but we do believe that it will have a meaningful improvement into our cash flow from operations for the rest of the year. Additionally, I think what's important, as we talked about in the last quarter, when we have our Encompass model, our operating model, materially all of our business is going through that operations. And so I think that's the more important point because that is going to go ahead and continue to drive the more efficient outcomes that we're talking about on the cost per submission. And so that's the primary thing I would guide you towards.
spk05: Yeah, and I'll add to that, Ben, that just as a disclaimer, right, we said early on this year with all the hard work the team's done that we wanted to standardize on the Encompass workflow. And that was for our internal captive channel. As you know, you have the external downline agencies who work with us and collaborate with us, but they're not on that same platform. So you would see the lion's share, if not all, of the volume running through the Encompass platform and the internal captive agents. And then externally, though we're starting to test that model, it's going to be a small portion of that. And so the majority of our external production will be running through the agency line. with the lion's share of the internal volume going through the non-agency line. So hopefully that's helpful to you, but I think it's confident to say that nearly all of the internal volume is going to be running through the Encompass workflow.
spk03: Thanks for that, Collar. And then separately, I was wondering if you could give us an update on how agent retention is trending. It seems like this plan fit checkup would be a Good way to support agent retention. Just any comments there?
spk05: Yeah, no. Thanks, Ben. On the question, I would say that our team has been super excited about what we've been doing with the tools we're providing for them to make their jobs easier, make it more efficient, a more standardized workflow that comes through Encompass. We have really committed and said out loud, as we said on these calls, that we were going to commit to doing the right thing and even paying our agents for not enrolling a beneficiary, but giving them a high-quality selling or shopping experience. And that was really important to us. So we augmented our compensation plans to do just that. If they deliver a high-quality shopping experience where they assess the individual's needs, match them with plans, present those to them, And even if they decide that they're already in the right plan and they tell them that, they will be compensated for that time that they spent and the high-quality work they did. That on top of the efficiencies delivered by our unified agent experience and even bringing in customer 360s, those bring efficiencies into the process that allow them to speak to more beneficiaries and more of our consumers. And so that gives them an opportunity to make more ultimately in that process. So with all those tools and our commitment to doing the right thing, which our agents want to do the right thing, and when we say we're now going to compensate them, even though many of them were already doing it, but now that we're compensating them for doing that, they realize they were aligned in our intentions to support consumers. The effect of that has been that our attrition is lower than we expected, and we are able to recruit at a higher pace, and we're recruiting when we need to add new agents with a With agents who are actually already licensed, they're actually more experienced in the space. And so in total, it's been a very, very exciting transition that the team's been able to work towards to achieve higher satisfaction amongst that group by delivering them tools and a very unique compensation model that's unparalleled in the industry.
spk11: Thank you.
spk01: Thank you and I'm showing no further questions at this time and I'd like to hand the conference back over to Vijay Kote for any further remarks.
spk05: Thanks again for joining us today. We are really excited about our progress. It is safe to say that we have been on a transformation. It has been an interesting transition over that timeframe over the last year plus. We deployed our Encompass strategy and it worked. We have shifted and can really stay focused to the fact that we've built a strong foundation upon which now to grow as we were able to grow this quarter with half of the agents that we used to have but still have year-over-year growth in this channel, built off of the hard work of our team. And so we hope you leave knowing we remain focused on delivering long-term value for our shareholders while providing high-quality experiences to our consumers and health plans. Thank you for your continued support. And we look forward to updating you on our progress during our next quarterly results call and webcast. Thank you.
spk01: This concludes today's conference call. Thank you for participating. You may now disconnect.
Disclaimer